Understanding FSGS and the Kidney Filters
Focal segmental glomerulosclerosis, commonly shortened to FSGS, is a pattern of scarring that affects the kidneys’ filtering units. Each kidney contains many tiny filters called glomeruli. These structures allow waste and extra fluid to pass into the urine while helping keep blood cells and important proteins in the bloodstream.
The name describes what is seen in kidney tissue. “Focal” means that only some glomeruli are affected, while “segmental” means that only part of an individual glomerulus may be scarred. Glomerulosclerosis refers to the scarring itself. Because the damage may be unevenly distributed, FSGS can affect people differently and may progress at different rates.
Nephrology Associates of Northern Illinois and Indiana (NANI) supports patients in Berwyn and North Chicago, Illinois, and Bergen, New Jersey, who are undergoing evaluation or monitoring for glomerular conditions such as FSGS. Understanding what the diagnosis represents can help patients make sense of urine protein results, swelling, kidney biopsies, and changes in filtration over time.
How FSGS Affects Kidney Function
Healthy glomeruli act as selective filters. They remove waste while preventing large quantities of protein from escaping into the urine. When parts of these filters become scarred, their ability to retain protein may be reduced.
Protein in the urine, or proteinuria, is one of the most important findings associated with FSGS. Some people have moderate protein loss, while others develop nephrotic-range proteinuria. Heavy protein loss may be accompanied by low albumin levels in the blood and swelling in the legs, feet, abdomen, or around the eyes.
Scarring may also reduce the number of filters working effectively. As more glomeruli are affected, estimated glomerular filtration rate, or eGFR, may decline. This change can happen gradually, and a person may feel well even while laboratory results show that kidney function is changing.
Learning more about kidney disease can provide useful context for how damage to the glomeruli affects filtration, fluid balance, blood pressure, and long-term kidney health.
FSGS Is Not a Single Disease With One Cause
FSGS is best understood as a pattern of kidney injury rather than one condition with a universal cause. Identifying why the scarring developed is important because the cause may influence treatment decisions and long-term expectations.
Primary FSGS is thought to involve a circulating factor that affects the glomerular filtration barrier. It often presents with nephrotic syndrome, which includes heavy proteinuria and low blood albumin, sometimes with significant swelling.
Secondary FSGS develops when the glomeruli are placed under prolonged stress. This may occur when the kidneys adapt to reduced kidney tissue, obesity, certain infections, medications, vascular changes, or other conditions that increase pressure within the filters.
Genetic forms are associated with inherited changes that affect proteins needed for normal glomerular structure or function. Genetic testing may be considered when FSGS develops at a young age, appears in multiple family members, does not respond as expected to treatment, or has other features suggesting an inherited cause.
In some cases, the cause remains uncertain even after a detailed evaluation. This uncertainty does not prevent monitoring or supportive care, but it may affect whether immunosuppressive treatment is considered.
Symptoms and Laboratory Changes
FSGS does not always cause noticeable symptoms at first. The condition may be discovered after routine testing shows protein in the urine or an unexpected change in kidney filtration.
When symptoms occur, they may reflect protein loss, fluid retention, or declining kidney function. Patients and clinicians may watch for:
- Foamy or persistently bubbly urine
- Swelling in the ankles, legs, abdomen, hands, or around the eyes
- Unexplained weight gain related to retained fluid
- Elevated or increasingly difficult-to-control blood pressure
- Fatigue, reduced appetite, or nausea as kidney function declines
- Changes in urine output or laboratory measurements
These symptoms are not specific to FSGS and can occur with other kidney or medical conditions. Testing is needed to determine whether glomerular damage is present and what may be causing it.
Why a Kidney Biopsy Is Often Necessary
Blood and urine tests can reveal protein loss and reduced filtration, but they cannot always determine the exact pattern of injury. A kidney biopsy is commonly used to diagnose FSGS and distinguish it from other glomerular diseases.
During a biopsy, a small sample of kidney tissue is removed and examined under a microscope. The pathologist looks for segmental scarring in some of the glomeruli and evaluates other features that may help classify the condition.
Because FSGS affects only some filters, the tissue sample must contain enough glomeruli to provide useful information. A biopsy may occasionally miss affected areas if the scarring is limited or unevenly distributed. The results are therefore interpreted alongside urine protein measurements, blood tests, medical history, and clinical presentation.
Additional evaluation may include testing for infections, autoimmune disease, medication effects, genetic variants, or other conditions that could produce secondary glomerular scarring.
Monitoring Proteinuria and Filtration Over Time
Long-term FSGS care involves more than repeating a single test. Healthcare teams generally follow trends in urine protein, serum creatinine, eGFR, blood albumin, blood pressure, body weight, and swelling.
Changes in proteinuria can provide important information about disease activity and treatment response. A meaningful reduction in urine protein may be associated with better long-term kidney outcomes, even if protein levels do not return completely to normal.
Kidney filtration is also monitored because declining eGFR may indicate progression. The rate of change matters: a slow decline over several years differs from a sudden shift that may reflect dehydration, illness, medication effects, or another acute problem.
Understanding how kidney function is measured can help patients interpret why creatinine, eGFR, urine protein, and blood pressure are followed together rather than viewed as unrelated numbers.
Treatment Depends on the Type of FSGS
There is no single treatment plan that applies to every person with FSGS. Management depends on whether the condition is considered primary, secondary, genetic, or of uncertain cause, as well as the severity of proteinuria and the degree of kidney impairment.
Supportive kidney care is important across many forms of FSGS. This may include controlling blood pressure, reducing protein loss, managing swelling, addressing cardiovascular risk, and reviewing medications that could affect the kidneys.
Immunosuppressive therapy may be considered for selected patients with primary FSGS and nephrotic syndrome. These medications are not automatically appropriate for every biopsy showing an FSGS pattern. When the condition is secondary or genetic, treating the underlying cause and reducing stress on the glomeruli may be more appropriate than suppressing the immune system.
Some patients require diuretics to help manage fluid retention. Nutrition recommendations may address sodium, protein, or other concerns according to kidney function and laboratory findings. Treatment decisions should be individualized because therapies can have significant benefits, risks, and monitoring requirements.
Daily Habits and Kidney Protection
Lifestyle changes cannot remove existing glomerular scars, but they may support the broader goals of kidney care. Blood pressure management, medication consistency, appropriate nutrition, and avoidance of additional kidney stress all contribute to the long-term plan.
Sodium reduction may help with swelling and blood pressure. Patients should also discuss nonprescription pain relievers, supplements, and herbal products with their healthcare team because some may affect kidney function or interact with prescribed treatment.
Regular activity can support cardiovascular health when it is appropriate for the individual’s condition. Smoking cessation is also important because tobacco use can damage blood vessels and increase cardiovascular and kidney-related risk.
Building a plan around kidney protection helps connect these daily decisions with the larger goals of preserving filtration, controlling blood pressure, and reducing avoidable strain on the kidneys.
What FSGS May Mean for Long-Term Kidney Health
The outlook for FSGS varies widely. Some patients respond well to treatment and maintain stable kidney function for many years. Others continue losing protein or experience a gradual decline in filtration despite treatment.
Several factors may influence the course of the condition, including the amount of protein in the urine, response to therapy, underlying cause, blood pressure control, kidney function at diagnosis, and degree of scarring seen on biopsy.
Not every patient with FSGS progresses to kidney failure. However, persistent heavy proteinuria and declining eGFR may indicate a higher risk of long-term loss of kidney function. This is why regular follow-up remains important even during periods when symptoms are mild.
If kidney function becomes severely reduced, discussions may eventually include dialysis or kidney transplantation. FSGS can sometimes recur in a transplanted kidney, particularly in certain forms of primary disease, so transplant planning may involve additional evaluation and counseling.
Coordinating Ongoing Nephrology Care
FSGS often requires long-term coordination among the nephrologist, primary care clinician, pathologist, dietitian, and other specialists. Genetic counselors or transplant teams may also become involved depending on the cause and stage of kidney disease.
Patients can support this process by keeping an updated medication list, completing laboratory testing as recommended, tracking blood pressure when advised, and reporting changes in swelling, weight, urine appearance, or overall health.
It is also helpful to ask how the FSGS has been classified and what the care team is monitoring. Understanding whether the condition appears primary, secondary, genetic, or uncertain can make the treatment approach easier to follow.
Looking Beyond a Single Test Result
FSGS describes scarring within some portions of the kidney’s filtering units, but the diagnosis alone does not predict exactly how the condition will progress. Protein levels, biopsy findings, kidney filtration, underlying cause, and treatment response must all be considered together.
Ongoing monitoring gives the nephrology team a clearer view of whether the disease is stable, responding to treatment, or placing kidney function at greater risk. Patients who understand these measurements may feel better prepared to participate in decisions about medication, nutrition, testing, and future care.
At its locations in Berwyn and North Chicago, Illinois, and Bergen, New Jersey, NANI provides nephrology care for individuals managing FSGS and other glomerular diseases. Consistent follow-up can help identify meaningful changes earlier and support a plan focused on preserving kidney function for as long as possible.
Sources
De Vriese, A. S., Sethi, S., Nath, K. A., Glassock, R. J., & Fervenza, F. C. (2018). Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. Journal of the American Society of Nephrology.
Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group. (2021). KDIGO clinical practice guideline for the management of glomerular diseases. Kidney International.
Rosenberg, A. Z., & Kopp, J. B. (2017). Focal segmental glomerulosclerosis. Clinical Journal of the American Society of Nephrology.
